CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 23 enrolled
Drug / intervention
Enoxaparin +1 moredrug
Likely dose
Enoxaparin 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00986076
NCT00986076Phase 4Completed
CompareCT.gov

Randomized Clinical Trial Evaluating Anti-inflammatory Effect of Low Molecular-Weight Heparin in Pediatric Cataract and Intraocular Lens Surgery

Iladevi Cataract and IOL Research Center·interventional·Posted Sep 29, 2009·Updated Sep 29, 2009

In Brief

A Phase 4 clinical trial evaluating Enoxaparin and Balanced Salt Solution for Inflammation. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if intraocular infusion of low-molecular weight heparin (enoxaparin) influences postoperative inflammation following pediatric cataract surgery with intraocular lens (IOL) implantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation
CountriesIndia
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 29, 2009
Enrollment StartMar 1, 2008
Primary CompletionApr 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.8 years ago

Interventions

Enoxaparindrug

Enoxaparin 40 mg / 500 ml in Balanced Salt Solution

Balanced Salt Solutiondrug

Intraocular infusion of Balanced Salt solution